Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66970-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- Nephrin antibody
- Antibody type
- Monoclonal
- Description
- Nephrin antibody (Cat. #66970-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D11H8
- Vial size
- 20ul, 150ul
Submitted references Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway.
Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment.
QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
Deciphering the pharmacological mechanisms of Rostellularia procumbens (L) Nees. Extract alleviates adriamycin-induced nephropathy in vivo and in vitro.
Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.
Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway.
Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Experimental study on renoprotective effect of intermedin on diabetic nephropathy.
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
Zhang X, Chen J, Lin R, Huang Y, Wang Z, Xu S, Wang L, Chen F, Zhang J, Pan K, Yin Z
Redox biology 2024 Sep;75:103246
Redox biology 2024 Sep;75:103246
Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment.
Huang B, Zhang Z, Sui W, Zhao L, Li Y, Feng L, Yang D, Zhou Y
Genomics 2024 Mar;116(2):110796
Genomics 2024 Mar;116(2):110796
QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
Gao F, Zhou Y, Yu B, Xie H, Shi Y, Zhang X, Liu H
Heliyon 2024 Jan 15;10(1):e23535
Heliyon 2024 Jan 15;10(1):e23535
Deciphering the pharmacological mechanisms of Rostellularia procumbens (L) Nees. Extract alleviates adriamycin-induced nephropathy in vivo and in vitro.
Ai Z, Wang M, Zhou Y, Yuan D, Jian Q, Wu S, Liu B, Yang Y
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 May;113:154736
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 May;113:154736
Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.
Song D, Zhang A, Hu X, Zeng M, Zhou H
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jul 25;116:154861
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jul 25;116:154861
Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway.
Han L, Wang S, Li J, Zhao L, Zhou H
Experimental and molecular pathology 2023 Dec;134:104877
Experimental and molecular pathology 2023 Dec;134:104877
Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D, Wang Y, Gui Y, Fu H, Zhou S, Wang Y, Bastacky SI, Stolz DB, Liu Y
Kidney international 2022 Jul;102(1):96-107
Kidney international 2022 Jul;102(1):96-107
Experimental study on renoprotective effect of intermedin on diabetic nephropathy.
Wang Y, Tian J, Mi Y, Ren X, Lian S, Kang J, Wang J, Zang H, Wu Z, Yang J, Qiao X, Zhou X, Wang G, Zhou Y, Li R
Molecular and cellular endocrinology 2021 May 15;528:111224
Molecular and cellular endocrinology 2021 May 15;528:111224
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
Yu J, Zhu C, Yin J, Yu D, Wan F, Tang X, Jiang X
Drug design, development and therapy 2020;14:361-370
Drug design, development and therapy 2020;14:361-370
No comments: Submit comment
No validations: Submit validation data